rs114350071

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004366.6(CLCN2):​c.2271+8T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00238 in 1,613,310 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0097 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 24 hom. )

Consequence

CLCN2
NM_004366.6 splice_region, intron

Scores

2
Splicing: ADA: 0.00001746
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.10

Publications

2 publications found
Variant links:
Genes affected
CLCN2 (HGNC:2020): (chloride voltage-gated channel 2) This gene encodes a voltage-gated chloride channel. The encoded protein is a transmembrane protein that maintains chloride ion homeostasis in various cells. Defects in this gene may be a cause of certain epilepsies. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
CLCN2 Gene-Disease associations (from GenCC):
  • leukoencephalopathy with mild cerebellar ataxia and white matter edema
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • epilepsy, idiopathic generalized, susceptibility to, 11
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • familial hyperaldosteronism type II
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 3-184352435-A-C is Benign according to our data. Variant chr3-184352435-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445441.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00973 (1482/152300) while in subpopulation AFR AF = 0.0316 (1315/41552). AF 95% confidence interval is 0.0302. There are 22 homozygotes in GnomAd4. There are 707 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCN2NM_004366.6 linkc.2271+8T>G splice_region_variant, intron_variant Intron 20 of 23 ENST00000265593.9 NP_004357.3 P51788-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCN2ENST00000265593.9 linkc.2271+8T>G splice_region_variant, intron_variant Intron 20 of 23 1 NM_004366.6 ENSP00000265593.4 P51788-1

Frequencies

GnomAD3 genomes
AF:
0.00971
AC:
1478
AN:
152182
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0316
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000661
Gnomad OTH
AF:
0.00909
GnomAD2 exomes
AF:
0.00347
AC:
868
AN:
249922
AF XY:
0.00275
show subpopulations
Gnomad AFR exome
AF:
0.0337
Gnomad AMR exome
AF:
0.00252
Gnomad ASJ exome
AF:
0.0112
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000842
Gnomad OTH exome
AF:
0.00262
GnomAD4 exome
AF:
0.00162
AC:
2364
AN:
1461010
Hom.:
24
Cov.:
33
AF XY:
0.00151
AC XY:
1100
AN XY:
726794
show subpopulations
African (AFR)
AF:
0.0331
AC:
1108
AN:
33472
American (AMR)
AF:
0.00320
AC:
143
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.00995
AC:
260
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000395
AC:
34
AN:
86170
European-Finnish (FIN)
AF:
0.0000757
AC:
4
AN:
52858
Middle Eastern (MID)
AF:
0.0102
AC:
59
AN:
5766
European-Non Finnish (NFE)
AF:
0.000469
AC:
522
AN:
1111866
Other (OTH)
AF:
0.00388
AC:
234
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
149
299
448
598
747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00973
AC:
1482
AN:
152300
Hom.:
22
Cov.:
32
AF XY:
0.00949
AC XY:
707
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0316
AC:
1315
AN:
41552
American (AMR)
AF:
0.00431
AC:
66
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
68024
Other (OTH)
AF:
0.00900
AC:
19
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
74
149
223
298
372
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00640
Hom.:
5
Bravo
AF:
0.0113
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.00107

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 02, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Familial hyperaldosteronism type II;C2750893:Epilepsy, idiopathic generalized, susceptibility to, 11;C4554120:Leukoencephalopathy with mild cerebellar ataxia and white matter edema Benign:1
Oct 02, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.27
DANN
Benign
0.48
PhyloP100
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000017
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114350071; hg19: chr3-184070223; API